Moderna Shares Down 17.2% on 2024 Sales Forecast Cut for Covid-19 and Rsv Vaccines
Moderna股票下跌17.2%,因爲Covid-19和Rsv疫苗的2024銷售預測下調。
Moderna Shares Down 17.2% on 2024 Sales Forecast Cut for Covid-19 and Rsv Vaccines
Moderna股票下跌17.2%,因爲Covid-19和Rsv疫苗的2024銷售預測下調。
使用瀏覽器的分享功能,分享給你的好友吧